View Agent
| Agent Info | |
| Agent: | trastuzumab |
| Synonyms: | Herceptin;Herceptin (TN);Trastuzumab (INN);Trastuzumab (genetical recombination);Trastuzumab (genetical recombination) (JAN) |
| Drug Status For Certain Diseases: | Breast cancer;Asthma(approved) |
| Classification: | a monoclonal antibody against human epidermal growth factor receptor 2 (human epidermal growth factor receptor 2;also known as ERBB2) |
| Target: | Receptor protein-tyrosine kinase erbB-2 |
| KEGG Pathway: | Pancreatic cancer non-small-cell lung cancer Adherens junction HIF-1 signaling pathway Prostate cancer Central carbon metabolism in cancer Focal adhesion MicroRNAs in cancer Pathways in cancer Calcium signaling pathway ErbB signaling pathway Bladder cancer Endometrial cancer |
| Wiki Pathway: | Leptin signaling pathway Signaling by ERBB2 Signaling Pathways in Glioblastoma EGF/EGFR Signaling Pathway Semaphorin interactions miR-targeted genes in muscle cell - TarBase ErbB Signaling Pathway Extracellular vesicle-mediated signaling in recipient cells Focal Adhesion Bladder Cancer DNA Damage Response (only ATM dependent) Integrated Pancreatic Cancer Pathway |